현재 펙사벡와 리브타요 병용요법(정맥투여방식) 환자군 11명 모집을 완료한 상태다.
Currently, the recruitment of a patient group of 11 in the combined modality therapy (intravenous administration method) of Pexa Vec and Libtayo has been completed.